🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HLA Antibodies in Systemic Lupus Erythematosus

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Universitaire, Amiens
NCT06921239 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients Adults * Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus * Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants) * With sera stored in the biobank Exclusion Criteria: * minor Patients * Opposing the re-use of their personal data for research purposes
💊

What it tests

  • Not listed
📍

Where

1 site
CHRU Amiens
Amiens, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy